New drug combo tested in fight against advanced liver cancer
Disease control
Not yet recruiting
This study is testing a new drug called MRG006A, given together with existing immunotherapy and targeted therapy drugs, for people with advanced liver cancer that cannot be removed by surgery. The main goals are to find a safe and effective dose and to see if this combination can…
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC